Medicine
Netspot kit
Netspot kit is a prescription medicine containing 68ga-dotatate for intravenous use, marketed by Advanced Accelerator Applications, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
For prolonged storage, store NETSPOT in its original packaging at room…
Key facts
- Active ingredient (INN)
- 68ga-dotatate
- Brand
- Netspot
- Dosage form
- Kit
- Route
- Intravenous
- Packs
- 1 kit
- Marketing authorisation holder
- Advanced Accelerator Applications
- Manufacturer
- Advanced Accelerator Applications
- Origin register
- US FDA, United States
- Storage
- For prolonged storage, store NETSPOT in its original packaging at room temperature below 25°C (77°F) (do not freeze). After radiolabeling with activities of up to 1,110 MBq (30 mCi), keep gallium Ga 68 dotatate injection upright with an appropriate shielding to protect from radiation, at a temperature below 25°C (77°F) (do not freeze), and use within 4 hours.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 June 2016
- Identifiers
- DailyMed set ID b2b3be70-17d8-4093-896c-f1c54a2cf242NDC 69488-001Application NDA208547
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 kit in 1 kit * 1 injection, powder, lyophilized, for solution in 1 vial, single-dose | 69488-001-40 | Advanced Accelerator Applications | 1 June 2016 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
68ga-dotatate is a prescription medicine indicated with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult and pediatric patients. It is available as kits for intravenous use. MedsAcross supplies 68ga-dotatate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about 68ga-dotatateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- NETSPOT prescribing information (Advanced Accelerator Applications) · U.S. National Library of Medicine, DailyMed
Need Netspot kit for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.